BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/19/2019 12:39:13 PM | Browse: 796 | Download: 1532
 |
Received |
|
2019-03-18 02:50 |
|
Peer-Review Started |
|
2019-03-18 06:26 |
|
To Make the First Decision |
|
2019-04-11 09:02 |
|
Return for Revision |
|
2019-04-12 02:51 |
|
Revised |
|
2019-04-18 16:21 |
|
Second Decision |
|
2019-06-05 10:33 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-06-08 15:04 |
|
Articles in Press |
|
2019-06-08 15:04 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-06-21 21:23 |
|
Typeset the Manuscript |
|
2019-07-17 00:28 |
|
Publish the Manuscript Online |
|
2019-07-19 12:39 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jing Cao, Fan-Hua Kong, Xi Liu and Xiao-Bo Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Bo Wang, MD, Surgeon, Department of surgery, Technical University of Munich, Arcisstrasse 21, Munich 80333, Germany. xiaobo.wang@tum.de |
| Key Words |
Hepatocellular carcinoma; Immunotherapy; Dendritic cells; Cytokine-induced killer cells |
| Core Tip |
Liver cancer, approximately 75% of which is ascribed to hepatocellular carcinoma, has been revealed as the second common cause of cancer-related death worldwide. Though several analyses have supported the effective benefit of cellular immunotherapy when combined with specific hepatocellular carcinoma (HCC) treatment, the efficacy and necessity of cellular immunotherapy after different interventional therapy remains to be interrogated. Our study suggested that the combination of immunotherapy with dendritic cells (DCs), cytokine-induced killer cells (CIKs) and DC-CIK with various routine HCC treatments could evidently improve patients’ prognosis by increasing the overall survival and reduce the recurrence of the malignancy. |
| Publish Date |
2019-07-19 12:39 |
| Citation |
Cao J, Kong FH, Liu X, Wang XB. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2019; 25(27): 3649-3663 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i27/3649.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i27.3649 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
